Arkolith/Insider Trading/SMMT/Form 4

Duggan Robert W

Co-Chief Executive Officer, Director, 10% OwnerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Sep 13, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Grant(A)3.3M$22.70$75.5M551.7M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-24-000139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML